Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis

Abstract Objective: Ulcerative colitis (UC) is characterized by mucosal inflammation and ulceration of the large intestine. Emu Oil (EO) has been reported to protect the intestine against mucositis, NSAID-enteropathy, UC-associated colorectal cancer and acute UC. We aimed to determine whether EO could reduce the severity chronic UC in mice. Methods: Female C57BL/6 mice (n = 10/group) were orally administered (gavage) water (Groups 1–2) or EO (Groups 3: low dose-80 µl and 4: high dose-160 µl), thrice weekly. Group 1 mice consumed plain drinking water throughout the trial. Groups 2–4 mice underwent two cycles [each consisting of seven days dextran sulfate sodium (DSS; 2% w/v) and 14 days water], followed by a third DSS week. All mice were euthanized two days later (day 51). Bodyweight, disease activity index (DAI), burrowing activity, myeloperoxidase activity, crypt depth and histologically assessed damage severity were assessed. p < .05 was considered significant. Results: DSS decreased bodyweight and increased DAI compared to normal controls (p < .05), which was partially attenuated by both EO doses (p < .05). Burrowing activity was impaired in DSS-controls compared to normal controls (days 27 and 40); an effect prevented by both EO doses (p < .05). DSS increased colonic myeloperoxidase activity and crypt depth compared to controls (p < .05), with no significant EO effect. Moreover, DSS increased colonic damage severity compared to normal controls (p < .001). Importantly, both EO doses decreased distal colonic damage severity compared to DSS-controls (p < .001). Conclusions: Emu Oil attenuated clinically- and histologically-assessed disease severity in a mouse model of chronic UC. Emu Oil demonstrates promise as an adjunct to conventional treatment options for UC management.

[1]  G. Howarth,et al.  Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil , 2018, Experimental biology and medicine.

[2]  I. Lawrance,et al.  Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer , 2017, Digestive Diseases and Sciences.

[3]  S. Mashtoub.  Potential therapeutic applications for emu oil , 2017 .

[4]  G. Eden,et al.  Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis , 2016, Nutrition and cancer.

[5]  K. Barrett,et al.  Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[6]  I. Lawrance,et al.  Tu1632 Emu Oil attenuates Disease Severity in Mouse Models of Colitis and Inflammation-Associated Colorectal Cancer , 2016 .

[7]  D. Bennett,et al.  Processing and storage of ratite oils affects primary oxidation status and radical scavenging ability , 2015 .

[8]  Paulin Jirkof,et al.  Burrowing and nest building behavior as indicators of well-being in mice , 2014, Journal of Neuroscience Methods.

[9]  G. Rogler,et al.  Chronic ulcerative colitis and colorectal cancer. , 2014, Cancer letters.

[10]  C. Feinle-Bisset,et al.  Clinical and Structural Effects of Traditional Chinese Medicine and the Herbal Preparation, Iberogast, in a Rat Model of Ulcerative Colitis , 2014, Journal of evidence-based complementary & alternative medicine.

[11]  G. Kolios,et al.  The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[12]  Å. Keita,et al.  Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis , 2013, Scandinavian journal of gastroenterology.

[13]  C. Tran,et al.  Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats , 2013, Experimental biology and medicine.

[14]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[15]  G. Rogler,et al.  Burrowing is a sensitive behavioural assay for monitoring general wellbeing during dextran sulfate sodium colitis in laboratory mice , 2013, Laboratory animals.

[16]  M. Sánchez-Hidalgo,et al.  Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. , 2013, The Journal of nutritional biochemistry.

[17]  J. Lindsay,et al.  Review article: strategies for the management of chronic unremitting ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.

[18]  S. Bastian,et al.  Grape Seed Extract Reduces the Severity of Selected Disease Markers in the Proximal Colon of Dextran Sulphate Sodium-Induced Colitis in Rats , 2013, Digestive Diseases and Sciences.

[19]  C. Tran,et al.  Emu Oil Reduces Small Intestinal Inflammation in the Absence of Clinical Improvement in a Rat Model of Indomethacin-Induced Enteropathy , 2013, Evidence-based complementary and alternative medicine : eCAM.

[20]  M. Scherer,et al.  Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss. , 2012, American journal of physiology. Endocrinology and metabolism.

[21]  C. Tran,et al.  Emu Oil: A novel therapeutic for disorders of the gastrointestinal tract? , 2012, Journal of gastroenterology and hepatology.

[22]  G. Howarth,et al.  Emu Oil Increases Colonic Crypt Depth in a Rat Model of Ulcerative Colitis , 2012, Digestive Diseases and Sciences.

[23]  J. Roughan,et al.  A comparison of a manual and an automated behavioural analysis method for assessing post-operative pain in mice , 2011 .

[24]  R. Deacon.  Burrowing: A sensitive behavioural assay, tested in five species of laboratory rodents , 2009, Behavioural Brain Research.

[25]  D. Bennett,et al.  Comparison of the antioxidant properties of emu oil with other avian oils , 2008 .

[26]  R. Gibson,et al.  Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. , 2007, Journal of lipid research.

[27]  K. Murphy,et al.  Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease , 2005, Journal of Gastroenterology.

[28]  M. Comalada,et al.  Biochemical and Molecular Actions of Nutrients Dietary Olive Oil Supplemented with Fish Oil , Rich in EPA and DHA ( n-3 ) Polyunsaturated Fatty Acids , Attenuates Colonic Inflammation in Rats with DSS-Induced Colitis 1 , 2005 .

[29]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[30]  R. Nicolosi,et al.  Antagonism of croton oil inflammation by topical emu oil in CD-1 mice , 2003, Lipids.

[31]  M. Swain,et al.  Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. , 2000, Gastroenterology.

[32]  C. Xian,et al.  Predisposition to Colonic Dysplasia is Unaffected by Continuous Administration of Insulin-like Growth Factor-1 for Twenty Weeks in a Rat Model of Chronic Inflammatory Bowel Disease , 2000, Growth factors.

[33]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[34]  M. Roberts,et al.  Emu oil(s): A source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine , 1998, InflammoPharmacology.

[35]  C. Xian,et al.  Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium. , 1998, Scandinavian journal of gastroenterology.

[36]  M. Whitehouse,et al.  Anti-inflammatory activity of emu oils in rats , 1997, InflammoPharmacology.